The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis
Open accessAbstract
Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be mediated by various Fc-receptor-expressing immune cells, including neutrophils. However, the mechanism(s) by which neutrophils kill antibody-opsonized cancer cells has not been established. Here, we demonstrate that neutrophils can exert a mode of destruction of cancer cells, which involves antibody-mediated trogocytosis by neutrophils. Intimately associated with this is an active mechanical disruption of the cancer cell plasma membrane, leading to a lytic (i.e., necrotic) type of cancer cell death. Furthermore, this mode of destruction of antibody-opsonized cancer cells by neutrophils is potentiated by CD47-SIRPα checkpoint blockade. Collectively, these findings show that neutrophil ADCC toward cancer cells occurs by a mechanism of cytotoxicity called trogoptosis, which can be further improved by targeting CD47-SIRPα interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Segal, A. W. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115653 · Cited by 1,789
Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,581
The SYK tyrosine kinase: A crucial player in diverse biological functions
Mócsai, A., Ruland, J., & Tybulewicz, V. L. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2765 · Cited by 1,368
Killing activity of neutrophils is mediated through activation of proteases by K+ flux
Reeves, E. P., Lu, H., Jacobs, H. L., Messina, C. G. M., Bolsover, S., Gabella, G., Potma, E. O., Warley, A., Roes, J., & Segal, A. W. (2002) · Nature · doi:10.1038/416291a · Cited by 1,153
Chao, M. P., Alizadeh, A. A., Tang, C., Myklebust, J. H., Varghese, B., Gill, S., Jan, M., Cha, A. C., Chan, C. K., Tan, B. T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.044 · Cited by 1,087
Musolino, A., Naldi, N., Bortesi, B., Pezzuolo, D., Capelletti, M., Missale, G., Laccabue, D., Zerbini, A., Camisa, R., Bisagni, G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8957 · Cited by 981
Barclay, A. N., & van den Berg, T. K. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120142 · Cited by 841
Chao, M. P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A. A., Gentles, A. J., Volkmer, J., Weiskopf, K., Willingham, S. B., Raveh, T., Park, C. Y., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001375 · Cited by 776
CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
Liu, X., Pu, Y., Cron, K., Deng, L., Kline, J., Frazier, W. A., Xu, H., Peng, H., Fu, Y.-X., & Xu, M. M. (2015) · Nature Medicine · doi:10.1038/nm.3931 · Cited by 767
Neutrophil granules: a library of innate immunity proteins
Borregaard, N., Sørensen, O. E., & Theilgaard-Mönch, K. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.06.002 · Cited by 739
Tseng, D., Volkmer, J.-P., Willingham, S. B., Contreras-Trujillo, H., Fathman, J. W., Fernhoff, N. B., Seita, J., Inlay, M. A., Weiskopf, K., Miyanishi, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305569110 · Cited by 657
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Eruslanov, E. B., Bhojnagarwala, P. S., Quatromoni, J. G., Stephen, T. L., Ranganathan, A., Deshpande, C., Akimova, T., Vachani, A., Litzky, L., Hancock, W. W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77053 · Cited by 644
What is trogocytosis and what is its purpose?
Joly, E., & Hudrisier, D. (2003) · Nature Immunology · doi:10.1038/ni0903-815 · Cited by 543
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
Sancho, D., Mourão-Sá, D., Joffre, O. P., Schulz, O., Rogers, N. C., Pennington, D. J., Carlyle, J. R., & Reis e Sousa, C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34584 · Cited by 519
Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
Weiskopf, K., Ring, A. M., Ho, C. C. M., Volkmer, J.-P., Levin, A. M., Volkmer, A. K., Özkan, E., Fernhoff, N. B., van de Rijn, M., Weissman, I. L., et al. (2013) · Science · doi:10.1126/science.1238856 · Cited by 495
Kuijpers, T., Tool, A., van der Schoot, C., Ginsel, L., Onderwater, J., Roos, D., & Verhoeven, A. (1991) · Blood · doi:10.1182/blood.v78.4.1105.1105 · Cited by 452
Self-citationMolecular mechanisms of biogenesis and exocytosis of cytotoxic granules
de Saint Basile, G., Ménasché, G., & Fischer, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2803 · Cited by 446
Ahrens, S., Zelenay, S., Sancho, D., Hanč, P., Kjær, S., Feest, C., Fletcher, G., Durkin, C., Postigo, A., Skehel, M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.008 · Cited by 398
Oxidative killing of microbes by neutrophils
Roos, D., van Bruggen, R., & Meischl, C. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.09.009 · Cited by 358
Self-citationAnti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
Ring, N. G., Herndler-Brandstetter, D., Weiskopf, K., Shan, L., Volkmer, J.-P., George, B. M., Lietzenmayer, M., McKenna, K. M., Naik, T. J., McCarty, A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710877114 · Cited by 283
Zhao, X. W., van Beek, E. M., Schornagel, K., Van der Maaden, H., Van Houdt, M., Otten, M. A., Finetti, P., Van Egmond, M., Matozaki, T., Kraal, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106550108 · Cited by 276
Self-citationMacrophages eliminate circulating tumor cells after monoclonal antibody therapy
Gül, N., Babes, L., Siegmund, K., Korthouwer, R., Bögels, M., Braster, R., Vidarsson, G., ten Hagen, T. L. M., Kubes, P., & van Egmond, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66776 · Cited by 275
Self-citationDifferential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
DiLillo, D. J., & Ravetch, J. V. (2015) · Cell · doi:10.1016/j.cell.2015.04.016 · Cited by 266
Cytotoxic immunological synapses
Dustin, M. L., & Long, E. O. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00904.x · Cited by 251
Trogocytosis by Entamoeba histolytica contributes to cell killing and tissue invasion
Ralston, K. S., Solga, M. D., Mackey-Lawrence, N. M., Somlata, Bhattacharya, A., & Petri, W. A. (2014) · Nature · doi:10.1038/nature13242 · Cited by 218
van Spriel, A. B., Leusen, J. H. W., van Egmond, M., Dijkman, H. B. P. M., Assmann, K. J. M., Mayadas, T. N., & van de Winkel, J. G. J. (2001) · Blood · doi:10.1182/blood.v97.8.2478 · Cited by 209
Self-citationMonoclonal Antibodies in Cancer Therapy: 25 Years of Progress
Oldham, R. K., & Dillman, R. O. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7438 · Cited by 204
Line of attack: NK cell specificity and integration of signals
Bryceson, Y. T., & Long, E. O. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.005 · Cited by 197
Soto-Pantoja, D. R., Terabe, M., Ghosh, A., Ridnour, L. A., DeGraff, W. G., Wink, D. A., Berzofsky, J. A., & Roberts, D. D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0037-t · Cited by 195
The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging
Montalvao, F., Garcia, Z., Celli, S., Breart, B., Deguine, J., Van Rooijen, N., & Bousso, P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70972 · Cited by 192
Hernandez‐Ilizaliturri, F. J., Jupudy, V., Ostberg, J. R., Oflazoglu, E., Huberman, A., Repasky, E. A., & Czuczman, M. S. (2003) · PubMed · Cited by 188
Martínez-Martín, N., Fernández-Arenas, E., Cemerski, S., Delgado, P., Turner, M., Heuser, J., Irvine, D. J., Huang, B., Bustelo, X. R., Shaw, A., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.06.003 · Cited by 183
Zhu, E. F., Gai, S. A., Opel, C. F., Kwan, B. H., Surana, R., Mihm, M. C., Kauke, M. J., Moynihan, K. D., Angelini, A., Williams, R. T., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.004 · Cited by 177
Hematologically important mutations: Leukocyte adhesion deficiency (first update)
van de Vijver, E., Maddalena, A., Sanal, Ö., Holland, S. M., Uzel, G., Madkaikar, M., de Boer, M., van Leeuwen, K., Köker, M. Y., Parvaneh, N., et al. (2012) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2011.10.004 · Cited by 177
Self-citationFcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities
Nimmerjahn, F., Gordan, S., & Lux, A. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.005 · Cited by 172
Taylor, R. P., & Lindorfer, M. A. (2014) · Blood · doi:10.1182/blood-2014-10-569244 · Cited by 163
Renaissance of cancer therapeutic antibodies
Glennie, M. J., & van de Winkel, J. G. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02714-4 · Cited by 155
Neutrophils mediate antibody-induced antitumor effects in mice
Albanesi, M., Mancardi, D. A., Jönsson, F., Iannascoli, B., Fiette, L., Santo, J. P. D., Lowell, C. A., & Bruhns, P. (2013) · Blood · doi:10.1182/blood-2013-04-497446 · Cited by 154
SHPS‐1 regulates integrin‐mediated cytoskeletal reorganization and cell motility
Inagaki, K., Yamao, T., Noguchi, T., Matozaki, T., Fukunaga, K., Takada, T., Hosooka, T., Akira, S., & Kasuga, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6721 · Cited by 143
Self-citationNeutrophils as effector cells for antibody-based immunotherapy of cancer
van Egmond, M., & Bakema, J. E. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.12.002 · Cited by 136
A Mechanistic Perspective of Monoclonal Antibodies in Cancer Therapy Beyond Target-Related Effects
Strome, S. E., Sausville, E. A., & Mann, D. L. (2007) · The Oncologist · doi:10.1634/theoncologist.12-9-1084 · Cited by 134
Meeths, M., Entesarian, M., Al–Herz, W., Chiang, S. C. C., Wood, S. M., Al-Ateeqi, W., Almazan, F., Boelens, J. J., Hasle, H., Ifversen, M., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282541 · Cited by 130
Self-citationRosseau, S., Selhorst, J., Wiechmann, K., Leissner, K., Maus, U. A., Mayer, K., Grimminger, F., Seeger, W., & Lohmeyer, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.427 · Cited by 121
Valgardsdottir, R., Cattaneo, I., Klein, C., Introna, M., Figliuzzi, M., & Golay, J. (2017) · Blood · doi:10.1182/blood-2016-08-735605 · Cited by 118
Yi, T., Li, J., Chen, H., Wu, J., An, J., Xu, Y., Hu, Y., Lowell, C. A., & Cyster, J. G. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.021 · Cited by 114
Calafat, J., Janssen, H., Ståhle‐Bäckdahl, M., Zuurbier, A. E. M., Knol, E. F., & Egesten, A. (1997) · Blood · doi:10.1182/blood.v90.3.1255.1255_1255_1266 · Cited by 109
Self-citationHawkins, P. T., Stephens, L., Suire, S., & Wilson, M. I. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_40 · Cited by 103
Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells
Velmurugan, R., Challa, D. K., Ram, S., Ober, R. J., & Ward, E. S. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0335 · Cited by 100
Siders, W., Shields, J. D., Garron, C., Hu, Y., Boutin, P., Shankara, S., Weber, W. D., Roberts, B., & Kaplan, J. M. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428191003777963 · Cited by 77
Mac-1 (CD11b/CD18) is crucial for effective Fc receptor–mediated immunity to melanoma
van Spriel, A. B., van Ojik, H. H., Bakker, A., Jansen, M., & van de Winkel, J. G. J. (2002) · Blood · doi:10.1182/blood.v101.1.253 · Cited by 74
Tintinger, G. R., Steel, H. C., & Anderson, R. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02800.x · Cited by 71
Rab27a Regulates Exocytosis of Tertiary and Specific Granules in Human Neutrophils
Herrero-Turrión, M. J., Calafat, J., Janssen, H., Fukuda, M., & Mollinedo, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3793 · Cited by 59
Self-citationAGC family kinase 1 participates in trogocytosis but not in phagocytosis in Entamoeba histolytica
Somlata, S., Nakada‐Tsukui, K., & Nozaki, T. (2017) · Nature Communications · doi:10.1038/s41467-017-00199-y · Cited by 59
Zhao, X. W., Gazendam, R. P., Drewniak, A., van Houdt, M., Tool, A. T. J., van Hamme, J. L., Kustiawan, I., Meijer, A. B., Janssen, H., Russell, D. G., et al. (2013) · Blood · doi:10.1182/blood-2013-03-494039 · Cited by 52
Self-citationTreffers, L. W., Zhao, X. W., van der Heijden, J., Nagelkerke, S. Q., van Rees, D. J., Gonzalez, P., Geissler, J., Verkuijlen, P., van Houdt, M., de Boer, M., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201747215 · Cited by 43
Self-citationOn the mechanism of CD47 targeting in cancer
Zhao, X. W., Matlung, H. L., Kuijpers, T. W., & van den Berg, T. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209265109 · Cited by 35
Self-citationFèvre, C., Bestebroer, J., Mebius, M. M., de Haas, C. J. C., van Strijp, J. A. G., Fitzgerald, J. R., & Haas, P. (2014) · Cellular Microbiology · doi:10.1111/cmi.12313 · Cited by 34
SIRPα Controls the Activity of the Phagocyte NADPH Oxidase by Restricting the Expression of gp91phox
van Beek, E. M., Zárate, J. Á., van Bruggen, R., Schornagel, K., Tool, A. T. J., Matozaki, T., Kraal, G., Roos, D., & van den Berg, T. K. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.027 · Cited by 32
Self-citationIs targeting of CD47-SIRPα enough for treating hematopoietic malignancy?
Zhao, X. W., Kuijpers, T. W., & van den Berg, T. K. (2012) · Blood · doi:10.1182/blood-2011-11-391367 · Cited by 32
Self-citationSoto‐Pantoja, D. R., Miller, T. W., Frazier, W. A., & Roberts, D. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205441109 · Cited by 25
Loss of CD47 Makes Dendritic Cells See Red
van den Berg, T. K., & van Bruggen, R. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.008 · Cited by 11
Cited by
Neutrophil diversity and plasticity in tumour progression and therapy
Jaillon, S., Ponzetta, A., Di Mitri, D., Santoni, A., Bonecchi, R., & Mantovani, A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0281-y · Cited by 1,285
Phagocytosis checkpoints as new targets for cancer immunotherapy
Feng, M., Jiang, W., Kim, B. Y. S., Zhang, C. C., Fu, Y.-X., & Weissman, I. L. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0183-z · Cited by 911
Neutrophil plasticity in the tumor microenvironment
Giese, M. A., Hind, L. E., & Huttenlocher, A. (2019) · Blood · doi:10.1182/blood-2018-11-844548 · Cited by 783
Neutrophils in cancer: heterogeneous and multifaceted
Hedrick, C. C., & Malanchi, I. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00571-6 · Cited by 768
Burn, G. L., Foti, A., Marsman, G., Patel, D. F., & Zychlinsky, A. (2021) · Immunity · doi:10.1016/j.immuni.2021.06.006 · Cited by 729
Metadata
- Authors
- Matlung, H. L., Babes, L., Zhao, X. W., van Houdt, M., Treffers, L. W., van Rees, D. J., Franke, K., Schornagel, K., Verkuijlen, P., Janssen, H., Halonen, P., Lieftink, C., Beijersbergen, R. L., Leusen, J. H. W., Boelens, J. J., Kuhnle, I., van der Werff Ten Bosch, J., Seeger, K., Rutella, S., Pagliara, D., Matozaki, T., Suzuki, E., Menke-van der Houven van Oordt, C. W., van Bruggen, R., Roos, D., van Lier, R. A. W., Kuijpers, T. W., Kubes, P., & van den Berg, T. K.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 23
- Issue
- 13
- Pages
- 3946-3959.e6
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2811247652
- Cited by
- 403
- References
- 66
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.